Kala Bio (KALA) Enterprise Value (2017 - 2026)
Kala Bio (KALA) recorded Enterprise Value of $19.22 million in Q2 2026, down 98.8% from $1.56 billion a year earlier and down 79.5% from the prior quarter.
Powered by 
Analysis
Kala Bio (KALA) Enterprise Value (2017 - 2026) Analysis & Trends
On a TTM basis, Kala Bio's Enterprise Value came in at -$18.2 million as of Jun 30, 2026; for FY2025, it came in at $218.97 million, down 82.7% from FY2024.
- Annual Enterprise Value has a five-year compound annual growth rate of -59.4% (FY2020 to FY2025).
- Across earlier years, Enterprise Value came in at $1.27 billion in FY2024 (+38.4%), $914.89 million in FY2023 (-71.6%), $3.22 billion in FY2022 (-16.8%) and $3.88 billion in FY2021 (-80.5%).
- The Q2 2026 figure is the lowest quarterly Enterprise Value in data going back to Q3 2017.
- On a year-over-year basis, Enterprise Value has declined for four consecutive quarters, with an average decline of 20.4% over the last eight quarters.
- Peak year-over-year performance for Enterprise Value in the last five years was growth of 68.7% in Q2 2023, against a decline of 98.8% in Q2 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $93.94 million (Q1 2026), $218.97 million (Q4 2025) and $547.52 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Kala Bio | 6.57 Mn | 6.57 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 19.22 Mn |
| Mar 31, 2026 | 93.94 Mn |
| Dec 31, 2025 | 218.97 Mn |
| Sep 30, 2025 | 547.52 Mn |
| Jun 30, 2025 | 1.56 Bn |
| Mar 31, 2025 | 1.81 Bn |
| Dec 31, 2024 | 1.27 Bn |
| Sep 30, 2024 | 1.26 Bn |
| Jun 30, 2024 | 1.02 Bn |
| Mar 31, 2024 | 1.07 Bn |
| Dec 31, 2023 | 914.89 Mn |
| Sep 30, 2023 | 1.14 Bn |
| Jun 30, 2023 | 1.79 Bn |
| Mar 31, 2023 | 1.67 Bn |
| Dec 31, 2022 | 3.22 Bn |
| Sep 30, 2022 | 763.45 Mn |
| Jun 30, 2022 | 1.06 Bn |
| Mar 31, 2022 | 4.99 Bn |
| Dec 31, 2021 | 3.88 Bn |
| Sep 30, 2021 | 8.50 Bn |
API Access
Kala Bio Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=KALA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "KALA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=KALA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();